Effects of the loss of Atox1 on the cellular pharmacology of cisplatin
Authors:
- Roohangiz SafaeiRSRoohangiz Safaei
- Mohammad H. MaktabiMMMohammad H. Maktabi
- Brian G. BlairBBBrian G. Blair
- Christopher A. LarsonCLChristopher A. Larson
- Stephen B. HowellSHStephen B. Howell
- 1 March 2009
- journal article
- Published by Elsevier in Journal of Inorganic Biochemistry
- Vol. 103 (3) , 333-341
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Novel Role of Antioxidant-1 (Atox1) as a Copper-dependent Transcription Factor Involved in Cell ProliferationJournal of Biological Chemistry, 2008
- Transport of Cisplatin by the Copper Efflux Transporter ATP7BMolecular Pharmacology, 2008
- Vertebrate Ctr1 coordinates morphogenesis and progenitor cell fate and regulates embryonic stem cell differentiationProceedings of the National Academy of Sciences, 2007
- The Internalization and Degradation of Human Copper Transporter 1 following Cisplatin ExposureCancer Research, 2006
- Structure of the Ctr1 copper trans‘PORE’ter reveals novel architectureTrends in Biochemical Sciences, 2006
- Molecular dynamics study of the metallochaperone Hah1 in its apo and Cu(I)-loaded states: Role of the conserved residue M10FEBS Letters, 2005
- Copper transporters regulate the cellular pharmacology and sensitivity to Pt drugsCritical Reviews in Oncology/Hematology, 2005
- Confocal Microscopic Analysis of the Interaction between Cisplatin and the Copper Transporter ATP7B in Human Ovarian Carcinoma CellsClinical Cancer Research, 2004
- Physical mapping of the humanHuman Genetics, 2000
- Identification and Functional Expression of HAH1, a Novel Human Gene Involved in Copper HomeostasisJournal of Biological Chemistry, 1997